Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

The effects of semaglutide on health-related quality of life in adults with type 2 diabetes and chronic kidney disease: FLOW trial

Authors :

Johannes Mann1,2; Ida Kirstine Bull Rasmussen3; Thomas P Gunnarsson3; Prachi Priyadarshini4; Søren Rasmussen3; Peter Rossing5

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download the poster (.pdf)
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Clinical